News | Artificial Intelligence | August 08, 2019

Half of Hospital Decision Makers Plan to Invest in AI by 2021

Survey shows hospitals realize AI’s market value, seeking to drive efficiency and reduce costs

Half of Hospital Decision Makers Plan to Invest in AI by 2021

August 8, 2019 — A recent study conducted by Olive AI explores how hospital leaders are responding to the imperative to drive efficiency and reduce costs through strategic investments in non-clinical technologies. The study audits the state of adoption and investment in artificial intelligence (AI) and robotic process automation (RPA).

The cost of healthcare is increasing, due in part to breakthroughs in patient care, including advancements in medical treatments and clinical technologies. However, the digitization of healthcare and the complexities of reimbursement are fundamentally changing the way hospital data is managed, adding new layers of administrative processes. The result: increasing operational expenses across hospitals and health systems.

The Olive AI survey found that: 

We are Still in the Early Stages of AI Adoption in Healthcare

  • Only 50 percent of hospital leaders interviewed said they were familiar with the concept of AI/RPA;
  • More than half of hospital leaders were unable to name an AI/RPA vendor or solution;
  • Twenty-three percent of hospital leaders are looking to invest in AI/RPA today, while half plan to do so by 2021; and
  • Those familiar with AI/RPA are two times as likely to implement AI to solve workflow challenges instead of leveraging existing systems

With an estimated $1 trillion of healthcare spending going toward administrative costs (labor being the largest component), hospital leaders are starting to look expansively at technology that improves efficiency across the enterprise.

Familiarity and Understanding of AI Impacts Decision-Making

  • Purchasing approaches vary. Forty-three percent of hospital leaders preferred to choose a company to build, deliver, monitor and support automations, 26 percent preferred to choose the platform themselves, then hire consultants to build their solution, 18 percent preferred to choose the platform themselves and have their employees build the solution, and 13 percent preferred to hire consultants to both choose the platform and build the solution;
  • Meanwhile, improving efficiency and reducing costs remains a top three priority (behind improving quality of care and improving patient satisfaction/engagement); and
  • Executives see high growth potential in automating high-volume, repetitive tasks in these functions: supply chain management, revenue cycle management, finance and human resources 

“As an industry, healthcare is united by a mission to deliver better patient care, and a huge barrier to delivering that promise is the challenge that 1 in every 3 dollars is spent on administrative expenses. Imagine what could be done if more resources were available to focus on patient care,” said Rebecca Hellmann, chief marketing officer of Olive. “With AI becoming more mainstream and offering a clearer path to value, hospitals no longer need to build out a massive technological infrastructure before benefiting from the efficiencies that it can create.”

Olive conducted this survey in partnership with Sage Growth Partners, an independent healthcare market research, consulting and marketing firm. The survey respondents included 115 executives spanning the roles of chief financial officers, chief information officers, revenue cycle managers and supply chain functional leaders at hospital systems and independent hospitals in the United States.

For more information: www.oliveai.com

Related Content

Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of mammography systems to Hologic’s state-of-the-art imaging technology
News | Breast Imaging | August 06, 2020
August 6, 2020 — RadNet, Inc., a national leader in providing hig
Intelerad Medical Systems, a leader in enterprise workflow solutions, announced the acquisition of Radius, a private cloud platform provider based in the Nashville, Tenn., metropolitan area.
News | Enterprise Imaging | August 05, 2020
August 5, 2020 — Intelerad Medical Systems, a leader in enterprise workflow solutions, announced the acquisition of
Keeping the health and safety of of the HIMSS audience in mind, the conference moves to August 9-13 in Las Vegas
News | HIMSS | August 03, 2020
August 3, 2020 —  The Healthcare Informatio...
Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions, and VasoTechnololgy, a subsidiary of the Vaso Corporation, announced an agreement to distribute Candelis' suite of image management PACS solutions and cloud services, including ImageGrid, ImageGrid Mini PACS and ASTRA Cloud.
News | Enterprise Imaging | July 29, 2020
July 29, 2020 — Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions,
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

News | Prostate Cancer | July 28, 2020
July 28, 2020 — A study published in 
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510